Eptacog Beta Efficacy and Safety in the Treatment and Control of Bleeding in Paediatric Subjects (<12 Years) with Hemophilia A or B with Inhibitors

Steven W Pipe, Cédric Hermans, Meera Chitlur, Manuel Carcao , Giancarlo Castaman, Joanna A Davis, Jonathan Ducore, Amy L Dunn, Miguel Escobar, Janna Journeycake, Osman Khan, Johnny Mahlangu, Shannon L Meeks, Ismail Haroon Mitha, Claude Négrier, Ulrike Nowak-Göttl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, Guy Young, W Allan Alexander, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Evelyne Sauty, Thomas A Wilkinson, Amy D Shapiro
April 27, 2022
Eptacog beta, Factor VII, 12 years and older

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.